Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigation of the Structure–Activity Relationships of Psilocybin Analogues
Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 533-542
Open Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Tryptamine based drugs
Shaun L. Greene
Comprehensive analytical chemistry (2025)
Closed Access
Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties
Jesper Eklund, Ulf Bremberg, Jessica Larsson, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Behavioral effects of three synthetic tryptamine derivatives in rodents
Rebecca Hill, Ritu A. Shetty, Nathalie Sumien, et al.
Journal of Psychopharmacology (2025)
Closed Access
CFH Loss in Human RPE Cells Leads to Inflammation and Complement System Dysregulation via the NF-κB Pathway
Angela Armento, Tiziana L. Schmidt, Inga Sonntag, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8727-8727
Open Access | Times Cited: 30
Structures and Biological Activities of Alkaloids Produced by Mushrooms, a Fungal Subgroup
Jesús G. Zorrilla, Antonio Evidente
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1025-1025
Open Access | Times Cited: 21
Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice
Grant C. Glatfelter, Marilyn Naeem, Duyen N. K. Pham, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 567-577
Closed Access | Times Cited: 12
Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice
Rika Takaba, Daisuke Ibi, Keisuke Yoshida, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 3019-3035
Open Access | Times Cited: 12
Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties
Pol Puigseslloses, Núria Nadal‐Gratacós, Gabriel Ketsela, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2346-2358
Open Access | Times Cited: 4
Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms
Ryan J. Rakoczy, Grace N. Runge, Abhishek K. Sen, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 19, pp. 3627-3641
Open Access | Times Cited: 4
Psilocybin and 2C-B at Encoding Distort Episodic Familiarity
Manoj K. Doss, Pablo Mallaroni, Natasha L. Mason, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 10, pp. 1048-1057
Closed Access | Times Cited: 4
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
I. Erkizia-Santamaría, Igor Horrillo, J. Javier Meana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111249-111249
Closed Access
Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT2A Receptor by a Light‐Controllable N,N‐Dimethyltryptamine Derivative
Hubert Gerwe, Feng He, Eline Pottie, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 26
Open Access | Times Cited: 16
Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders
Sheetal A. Raithatha, Jillian M. Hagel, Kaveh Matinkhoo, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 2, pp. 1024-1043
Open Access | Times Cited: 10
Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue
Gregory Ian Robinson, Dongping Li, Bo Wang, et al.
Life (2023) Vol. 13, Iss. 12, pp. 2345-2345
Open Access | Times Cited: 10
The evolution and ecology of psilocybin in nature
Matthew J. Meyer, Jason C. Slot
Fungal Genetics and Biology (2023) Vol. 167, pp. 103812-103812
Closed Access | Times Cited: 9
Identification of 5-HT2AReceptor Signaling Pathways Responsible for Psychedelic Potential
Jason Wallach, Andrew B. Cao, Maggie M. Calkins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
The use of prodrugs as drugs of abuse
Julio Ponce
Wiley Interdisciplinary Reviews Forensic Science (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 3
Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists
Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7224-7244
Open Access | Times Cited: 3
Cellular rules underlying psychedelic control of prefrontal pyramidal neurons
Tyler G. Ekins, Isla Brooks, Sameer Kailasa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon
Val Bellman
Cancers (2024) Vol. 16, Iss. 9, pp. 1702-1702
Open Access | Times Cited: 2
RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
Nathan Bryson, Robert Alexander, Aviva Asnis-Alibozek, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 12, pp. 2386-2395
Open Access | Times Cited: 2
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Gabriele Floris, Konrad Dabrowski, Mary Tresa Zanda, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 2
Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines
Grant C. Glatfelter, Duyen N. K. Pham, Donna Walther, et al.
ACS Omega (2022) Vol. 7, Iss. 28, pp. 24888-24894
Open Access | Times Cited: 12
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework
Manon van den Berg, Igor Magaraggia, Rudy Schreiber, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1853-1879
Open Access | Times Cited: 11
Utility of preclinical models in the study of psilocybin – A comprehensive review
Megan Pedicini, Zachary A. Cordner
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105046-105046
Closed Access | Times Cited: 6

Scroll to top